Stay updated with breaking news from India Based Intas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. military officials are so concerned about the quality of generic drugs that the Department of Defense is devising a program to test the safety of widely used medicines.
"We're concerned, we're anxious," oncology chief at Lee Heath says of cancer drug shortage.
Comera Life Sciences announced that it will collaborate with Intas Pharmaceuticals to develop a new generation of biologic medicines.